| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-(1->3)-fucosyltransferase activity | 4.25e-13 | 8 | 102 | 6 | GO:0046920 | |
| GeneOntologyMolecularFunction | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity | 1.88e-11 | 6 | 102 | 5 | GO:0017083 | |
| GeneOntologyMolecularFunction | fucosyltransferase activity | 4.45e-11 | 14 | 102 | 6 | GO:0008417 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 6.91e-06 | 194 | 102 | 8 | GO:0016705 | |
| GeneOntologyMolecularFunction | heme binding | 1.42e-05 | 154 | 102 | 7 | GO:0020037 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.13e-05 | 164 | 102 | 7 | GO:0046906 | |
| GeneOntologyMolecularFunction | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity | 2.58e-05 | 2 | 102 | 2 | GO:0017060 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 2.75e-05 | 115 | 102 | 6 | GO:0004497 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 5.09e-05 | 40 | 102 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 1.05e-04 | 211 | 102 | 7 | GO:0016758 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.15e-04 | 288 | 102 | 8 | GO:0016757 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.56e-04 | 5 | 102 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 3.82e-04 | 6 | 102 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 5.34e-04 | 7 | 102 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 5.34e-04 | 7 | 102 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | symporter activity | 1.04e-03 | 150 | 102 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 1.13e-03 | 10 | 102 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 1.13e-03 | 10 | 102 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 1.13e-03 | 10 | 102 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.63e-03 | 166 | 102 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.63e-03 | 430 | 102 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 1.94e-03 | 13 | 102 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.94e-03 | 13 | 102 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | aminoacyl-tRNA editing activity | 2.26e-03 | 14 | 102 | 2 | GO:0002161 | |
| GeneOntologyMolecularFunction | arachidonate binding | 2.60e-03 | 15 | 102 | 2 | GO:0050544 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 2.93e-03 | 190 | 102 | 5 | GO:0004252 | |
| GeneOntologyMolecularFunction | icosanoid binding | 2.96e-03 | 16 | 102 | 2 | GO:0050542 | |
| GeneOntologyMolecularFunction | icosatetraenoic acid binding | 2.96e-03 | 16 | 102 | 2 | GO:0050543 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 4.14e-03 | 296 | 102 | 6 | GO:0015291 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 4.22e-03 | 207 | 102 | 5 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 4.66e-03 | 212 | 102 | 5 | GO:0017171 | |
| GeneOntologyMolecularFunction | neurotransmitter transmembrane transporter activity | 5.09e-03 | 21 | 102 | 2 | GO:0005326 | |
| GeneOntologyBiologicalProcess | fucosylation | 2.23e-10 | 18 | 102 | 6 | GO:0036065 | |
| GeneOntologyBiologicalProcess | L-fucose catabolic process | 6.97e-08 | 9 | 102 | 4 | GO:0042355 | |
| GeneOntologyBiologicalProcess | fucose catabolic process | 6.97e-08 | 9 | 102 | 4 | GO:0019317 | |
| GeneOntologyBiologicalProcess | L-fucose metabolic process | 1.16e-07 | 10 | 102 | 4 | GO:0042354 | |
| GeneOntologyBiologicalProcess | oligosaccharide biosynthetic process | 4.11e-07 | 31 | 102 | 5 | GO:0009312 | |
| GeneOntologyBiologicalProcess | fucose metabolic process | 9.80e-07 | 16 | 102 | 4 | GO:0006004 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 2.51e-05 | 70 | 102 | 5 | GO:0009311 | |
| GeneOntologyBiologicalProcess | hexose catabolic process | 1.37e-04 | 53 | 102 | 4 | GO:0019320 | |
| GeneOntologyBiologicalProcess | membrane lipid metabolic process | 1.43e-04 | 229 | 102 | 7 | GO:0006643 | |
| GeneOntologyBiologicalProcess | lymphocyte migration into lymph node | 1.44e-04 | 4 | 102 | 2 | GO:0097022 | |
| GeneOntologyBiologicalProcess | monosaccharide catabolic process | 1.82e-04 | 57 | 102 | 4 | GO:0046365 | |
| GeneOntologyBiologicalProcess | lipoprotein biosynthetic process | 1.83e-04 | 106 | 102 | 5 | GO:0042158 | |
| GeneOntologyBiologicalProcess | detection of external stimulus | 2.21e-04 | 173 | 102 | 6 | GO:0009581 | |
| GeneOntologyBiologicalProcess | detection of abiotic stimulus | 2.35e-04 | 175 | 102 | 6 | GO:0009582 | |
| GeneOntologyBiologicalProcess | N-glycan fucosylation | 2.40e-04 | 5 | 102 | 2 | GO:0036071 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 2.57e-04 | 252 | 102 | 7 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 2.57e-04 | 252 | 102 | 7 | GO:0006486 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 3.59e-04 | 6 | 102 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | glycosylation | 3.90e-04 | 270 | 102 | 7 | GO:0070085 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 3.97e-04 | 357 | 102 | 8 | GO:0009101 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 5.00e-04 | 7 | 102 | 2 | GO:0036102 | |
| GeneOntologyBiologicalProcess | protein N-linked glycosylation | 5.50e-04 | 76 | 102 | 4 | GO:0006487 | |
| GeneOntologyCellularComponent | Golgi cisterna | 4.44e-06 | 135 | 102 | 7 | GO:0031985 | |
| GeneOntologyCellularComponent | Golgi cisterna membrane | 6.69e-06 | 94 | 102 | 6 | GO:0032580 | |
| GeneOntologyCellularComponent | Golgi stack | 2.08e-05 | 171 | 102 | 7 | GO:0005795 | |
| Domain | Glyco_transf_10 | 5.28e-13 | 8 | 99 | 6 | PF00852 | |
| Domain | Glyco_tran_10_N | 5.28e-13 | 8 | 99 | 6 | PF17039 | |
| Domain | Glyco_trans_10 | 5.28e-13 | 8 | 99 | 6 | IPR001503 | |
| Domain | Glyco_tran_10_N | 5.28e-13 | 8 | 99 | 6 | IPR031481 | |
| Domain | Cyt_P450_CS | 8.86e-06 | 53 | 99 | 5 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 1.27e-05 | 57 | 99 | 5 | PS00086 | |
| Domain | - | 1.39e-05 | 58 | 99 | 5 | 1.10.630.10 | |
| Domain | p450 | 1.39e-05 | 58 | 99 | 5 | PF00067 | |
| Domain | Cyt_P450 | 1.64e-05 | 60 | 99 | 5 | IPR001128 | |
| Domain | Cyt_P450_E_grp-I | 9.37e-05 | 45 | 99 | 4 | IPR002401 | |
| Domain | p53-like_TF_DNA-bd | 1.78e-04 | 53 | 99 | 4 | IPR008967 | |
| Domain | NUT | 2.75e-04 | 5 | 99 | 2 | IPR024310 | |
| Domain | DZF | 2.75e-04 | 5 | 99 | 2 | SM00572 | |
| Domain | NUT_N | 2.75e-04 | 5 | 99 | 2 | IPR024309 | |
| Domain | Anion_exchange | 2.75e-04 | 5 | 99 | 2 | IPR001717 | |
| Domain | NUT | 2.75e-04 | 5 | 99 | 2 | PF12881 | |
| Domain | DZF_dom | 2.75e-04 | 5 | 99 | 2 | IPR006561 | |
| Domain | DZF | 2.75e-04 | 5 | 99 | 2 | PF07528 | |
| Domain | DZF | 2.75e-04 | 5 | 99 | 2 | PS51703 | |
| Domain | ANION_EXCHANGER_2 | 5.74e-04 | 7 | 99 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 5.74e-04 | 7 | 99 | 2 | PS00219 | |
| Domain | Band3_cytoplasmic_dom | 9.77e-04 | 9 | 99 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 9.77e-04 | 9 | 99 | 2 | PF07565 | |
| Domain | Rhomboid | 9.77e-04 | 9 | 99 | 2 | PF01694 | |
| Domain | - | 9.77e-04 | 9 | 99 | 2 | 3.40.1100.10 | |
| Domain | Peptidase_S54_rhomboid_dom | 9.77e-04 | 9 | 99 | 2 | IPR022764 | |
| Domain | - | 9.77e-04 | 9 | 99 | 2 | 1.20.1540.10 | |
| Domain | Orgcat_transp/SVOP | 9.77e-04 | 9 | 99 | 2 | IPR004749 | |
| Domain | Cyt_P450_E_grp-IV | 1.22e-03 | 10 | 99 | 2 | IPR002403 | |
| Domain | HCO3_cotransp | 1.22e-03 | 10 | 99 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 1.22e-03 | 10 | 99 | 2 | IPR011531 | |
| Domain | PTrfase/Anion_transptr | 1.22e-03 | 10 | 99 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 1.22e-03 | 10 | 99 | 2 | IPR003020 | |
| Domain | DSRM | 4.48e-03 | 19 | 99 | 2 | SM00358 | |
| Domain | Fd_Rdtase_FAD-bd | 4.48e-03 | 19 | 99 | 2 | IPR017927 | |
| Domain | FAD_FR | 4.48e-03 | 19 | 99 | 2 | PS51384 | |
| Domain | Riboflavin_synthase-like_b-brl | 4.48e-03 | 19 | 99 | 2 | IPR017938 | |
| Domain | dsrm | 4.97e-03 | 20 | 99 | 2 | PF00035 | |
| Domain | DS_RBD | 5.47e-03 | 21 | 99 | 2 | PS50137 | |
| Pathway | KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 1.25e-11 | 6 | 67 | 5 | M47967 | |
| Pathway | REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS | 4.70e-10 | 21 | 67 | 6 | M27917 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS | 2.32e-09 | 5 | 67 | 4 | M47966 | |
| Pathway | KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES | 1.27e-07 | 26 | 67 | 5 | M17377 | |
| Pathway | BIOCARTA_AMAN_PATHWAY | 6.12e-07 | 15 | 67 | 4 | M22009 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 9.66e-06 | 104 | 67 | 6 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 1.02e-05 | 105 | 67 | 6 | MM14842 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.28e-05 | 64 | 67 | 5 | M5650 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.49e-05 | 66 | 67 | 5 | MM14839 | |
| Pathway | REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS | 6.65e-05 | 17 | 67 | 3 | MM15629 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 2.11e-04 | 62 | 67 | 4 | M39653 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 4.21e-04 | 288 | 67 | 7 | M16864 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX | 5.06e-04 | 33 | 67 | 3 | MM15918 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 5.95e-04 | 219 | 67 | 6 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 6.09e-04 | 220 | 67 | 6 | M10320 | |
| Pathway | BIOCARTA_AMAN_PATHWAY | 7.84e-04 | 9 | 67 | 2 | MM1535 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 9.77e-04 | 10 | 67 | 2 | M27335 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 9.77e-04 | 10 | 67 | 2 | MM15073 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 1.11e-03 | 43 | 67 | 3 | MM15873 | |
| Pathway | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | 1.42e-03 | 12 | 67 | 2 | MM15192 | |
| Pathway | REACTOME_EICOSANOIDS | 1.42e-03 | 12 | 67 | 2 | M27129 | |
| Pathway | REACTOME_EICOSANOIDS | 1.42e-03 | 12 | 67 | 2 | MM14845 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 1.76e-03 | 183 | 67 | 5 | M39588 | |
| Pubmed | Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. | 3.21e-12 | 15 | 105 | 6 | 11698403 | |
| Pubmed | Distinct human α(1,3)-fucosyltransferases drive Lewis-X/sialyl Lewis-X assembly in human cells. | 3.91e-10 | 5 | 105 | 4 | 29593094 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 7650030 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 30808544 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 7782074 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 1740457 | ||
| Pubmed | 1.07e-07 | 4 | 105 | 3 | 19349624 | ||
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 2.25e-07 | 44 | 105 | 5 | 12745259 | |
| Pubmed | 2.36e-06 | 70 | 105 | 5 | 15128046 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22359671 | ||
| Pubmed | α(1,3)-Fucosyltransferases FUT4 and FUT7 control murine susceptibility to thrombosis. | 9.03e-06 | 2 | 105 | 2 | 23562273 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29345354 | ||
| Pubmed | NOX1 abet mesangial fibrogenesis via iNOS induction in diabetes. | 9.03e-06 | 2 | 105 | 2 | 23801050 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8752218 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31104223 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11485743 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16709814 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21978830 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11687802 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17916350 | ||
| Pubmed | Memory T cells are enriched in lymph nodes of selectin-ligand-deficient mice. | 9.03e-06 | 2 | 105 | 2 | 20937846 | |
| Pubmed | Correlation of FUT3 and FUT6 Gene Polymorphisms With Helicobacter pylori Infection. | 9.03e-06 | 2 | 105 | 2 | 39108208 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16112640 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22329647 | ||
| Pubmed | iNOS- and NOX1-dependent ROS production maintains bacterial homeostasis in the ileum of mice. | 9.03e-06 | 2 | 105 | 2 | 29210363 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20965272 | ||
| Pubmed | Selectin ligand-independent priming and maintenance of T cell immunity during airborne tuberculosis. | 9.03e-06 | 2 | 105 | 2 | 16394002 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18778282 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17604274 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7721776 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 34910522 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17928512 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16127157 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15579466 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11535629 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29491007 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 1339443 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19608009 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28656540 | ||
| Pubmed | Pathophysiological contributions of fucosyltransferases in renal ischemia reperfusion injury. | 9.03e-06 | 2 | 105 | 2 | 12193737 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 23192350 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 19567674 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 12869507 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 22456610 | ||
| Pubmed | Cochlear outer hair cell horizontal top connectors mediate mature stereocilia bundle mechanics. | 2.70e-05 | 3 | 105 | 2 | 30801007 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24244288 | ||
| Pubmed | A new double-stranded RNA-binding protein that interacts with PKR. | 2.70e-05 | 3 | 105 | 2 | 10684936 | |
| Pubmed | Platelet regulation by NO/cGMP signaling and NAD(P)H oxidase-generated ROS. | 2.70e-05 | 3 | 105 | 2 | 16469512 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24232099 | ||
| Pubmed | A role for leukocyte-endothelial adhesion mechanisms in epilepsy. | 2.70e-05 | 3 | 105 | 2 | 19029985 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 15843584 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 7519613 | ||
| Pubmed | Naïve T cells re-distribute to the lungs of selectin ligand deficient mice. | 2.70e-05 | 3 | 105 | 2 | 20532047 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 16352740 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 20605574 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 16338500 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 20179215 | ||
| Pubmed | Binding of L-selectin to its vascular and extravascular ligands is differentially regulated by pH. | 2.70e-05 | 3 | 105 | 2 | 21982762 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 15308551 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 24322980 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 11278338 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 32341362 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 25317947 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 23657464 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 18292449 | ||
| Pubmed | Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. | 2.70e-05 | 3 | 105 | 2 | 22388819 | |
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 2.70e-05 | 3 | 105 | 2 | 26542179 | |
| Pubmed | Stereocilin-deficient mice reveal the origin of cochlear waveform distortions. | 5.40e-05 | 4 | 105 | 2 | 18849963 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 27488527 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 29500244 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 28771224 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 22665481 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 23986452 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 14592810 | ||
| Pubmed | Expression and catalytic activity of mouse leukotriene B4 omega-hydroxylase, CYP4F14. | 5.40e-05 | 4 | 105 | 2 | 11185557 | |
| Pubmed | Arteriogenesis proceeds via ICAM-1/Mac-1- mediated mechanisms. | 5.40e-05 | 4 | 105 | 2 | 15059933 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 18755847 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 37735247 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 22194593 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 8914934 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 10894166 | ||
| Pubmed | Notch-dependent control of myelopoiesis is regulated by fucosylation. | 5.40e-05 | 4 | 105 | 2 | 18359890 | |
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 7656588 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 22461691 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 18050214 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 18056398 | ||
| Pubmed | 7.50e-05 | 730 | 105 | 10 | 34857952 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 23500099 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 22969154 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 18037890 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 16227985 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 22029643 | ||
| Pubmed | Cytochrome P4504f, a potential therapeutic target limiting neuroinflammation. | 8.97e-05 | 5 | 105 | 2 | 21466787 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 17320454 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 15501800 | ||
| Pubmed | Genetic polymorphisms in mediators of inflammation and gastric precancerous lesions. | 8.97e-05 | 5 | 105 | 2 | 18287876 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 24920589 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 26121233 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 20929857 | ||
| Pubmed | The rhomboid protease family: a decade of progress on function and mechanism. | 1.34e-04 | 6 | 105 | 2 | 22035660 | |
| Cytoband | 7q21.2 | 5.34e-04 | 15 | 105 | 2 | 7q21.2 | |
| Cytoband | 19q13.32 | 6.70e-04 | 74 | 105 | 3 | 19q13.32 | |
| Cytoband | 10q23.2 | 6.89e-04 | 17 | 105 | 2 | 10q23.2 | |
| GeneFamily | Fucosyltransferases|Blood group antigens | 2.60e-12 | 13 | 64 | 6 | 434 | |
| GeneFamily | Cytochrome P450 family 4 | 2.78e-04 | 36 | 64 | 3 | 1003 | |
| GeneFamily | Rhomboid family | 1.09e-03 | 14 | 64 | 2 | 926 | |
| GeneFamily | Proteases, serine | 1.44e-03 | 63 | 64 | 3 | 738 | |
| GeneFamily | Glycosyl transferases group 1 domain containing|Phosphatidylinositol glycan anchor biosynthesis | 2.48e-03 | 21 | 64 | 2 | 680 | |
| GeneFamily | G protein-coupled receptors, Class A orphans | 2.66e-03 | 78 | 64 | 3 | 262 | |
| GeneFamily | Solute carriers | 2.70e-03 | 395 | 64 | 6 | 752 | |
| GeneFamily | Actins|Deafness associated genes | 7.51e-03 | 113 | 64 | 3 | 1152 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 7.59e-03 | 37 | 64 | 2 | 454 | |
| Coexpression | WAGNER_APO2_SENSITIVITY | 7.28e-10 | 26 | 104 | 6 | M13240 | |
| Coexpression | GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN | 1.44e-05 | 198 | 104 | 7 | M6731 | |
| Coexpression | GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN | 1.47e-05 | 132 | 104 | 6 | M425 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-06 | 176 | 105 | 6 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 182 | 105 | 6 | 678eadd57e7e830fc2bf9fd35616d3badce01705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-papillary_tips_cell-Papillary_Tip_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.66e-06 | 182 | 105 | 6 | 8d1229fa5aa6e2e38f2ac6fe4f4dc89752fe9344 | |
| ToppCell | distal-Epithelial-Proximal_Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | c102b28d5d1d90b9f7024cb51114276354be26a5 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.12e-06 | 196 | 105 | 6 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | distal-Epithelial-Proximal_Basal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | a543d4623096cb3f9170dbf7af52381e77aa435e | |
| ToppCell | distal-3-Epithelial-Proximal_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.12e-06 | 196 | 105 | 6 | 7e1a565dd2da4f375cbce8842ba4fd6c22ac8375 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 7.33e-06 | 197 | 105 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pax5_(SN/VTA_(SNr))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.51e-06 | 53 | 105 | 4 | ef2fa0364d7807cec2c0a45f940837cac6d22e43 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pax5_(SN/VTA_(SNr))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.51e-06 | 53 | 105 | 4 | 974757404e411d7a0d762d21db07f9632a838be3 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pax5_(SN/VTA_(SNr))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 7.51e-06 | 53 | 105 | 4 | ad3eac1ffca39ace1ea1284441c60fe55b1a8470 | |
| ToppCell | Basal_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.36e-05 | 164 | 105 | 5 | 85487a303194f5244956ec1ca2d1758d38117f41 | |
| ToppCell | TCGA-Colorectal|World / Sample_Type by Project: Shred V9 | 4.61e-05 | 166 | 105 | 5 | c018cd8c7a82251c67e3dc812d4d21e527a43456 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.17e-05 | 170 | 105 | 5 | aabe993c9f337b1caaeb0e64626a3920579c41b7 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.46e-05 | 172 | 105 | 5 | b66dbfff5e4f53ca8ece91ff9c5dc66a71f07c63 | |
| ToppCell | RSV-Healthy-1|Healthy / Virus stimulation, Condition and Cluster | 5.93e-05 | 175 | 105 | 5 | ff3a27f512a3a710ebc863b7b75cce8167d5440b | |
| ToppCell | RSV-Healthy-1|RSV / Virus stimulation, Condition and Cluster | 5.93e-05 | 175 | 105 | 5 | ca52b99b03535a5b3a2751d6981708dc5b255b91 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.26e-05 | 177 | 105 | 5 | d6596a0b6fd146fefc27717c1a7dbaa3774cc644 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-05 | 178 | 105 | 5 | 4ef6344d0ffc9c55b1240bee94b741382f1427bb | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.43e-05 | 178 | 105 | 5 | c65932cbedbbfacb6f0299280663fe7c88dba72b | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.43e-05 | 178 | 105 | 5 | fba2e38c05cbf031e0c6d47b1602575fea734a57 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.97e-05 | 93 | 105 | 4 | 38a075f06001a2fd1ec77fc301a08a87618a2440 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.97e-05 | 93 | 105 | 4 | a0117b12889d9c48294a7ccea4284d00c087889f | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Gkn3_(Gkn3)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.97e-05 | 93 | 105 | 4 | b3e057132633b25bd4f8ff2c0aa203ade0f3ba4c | |
| ToppCell | wk_08-11-Hematologic-Myeloid-pre-pDC/DC5|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.14e-05 | 182 | 105 | 5 | fec8a2d6d4099722b8e1bb41222108ed74268fcf | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-parabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.91e-05 | 186 | 105 | 5 | 18c06041c6c8a0ebac17b3c8aaebd67e652d315a | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 8.11e-05 | 187 | 105 | 5 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.32e-05 | 188 | 105 | 5 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 8.32e-05 | 188 | 105 | 5 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 8.96e-05 | 191 | 105 | 5 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-H_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 9.18e-05 | 192 | 105 | 5 | 7a6dd2ae217b8f8e460d47ad128904408299458c | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 1.01e-04 | 196 | 105 | 5 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 196 | 105 | 5 | 5789b5b0763d6eab21bf4da1fd8eae6116f46f3f | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 196 | 105 | 5 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.01e-04 | 196 | 105 | 5 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.01e-04 | 196 | 105 | 5 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.01e-04 | 196 | 105 | 5 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.01e-04 | 196 | 105 | 5 | 8e96fc87812d112ccae6e2ca1821bee1ee2efe48 | |
| ToppCell | distal-Epithelial-Goblet|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-04 | 197 | 105 | 5 | da1ed7303cc9cb2d205c0e5c49c52544d3540951 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|Epithelial / Condition, Lineage and Cell class | 1.04e-04 | 197 | 105 | 5 | 78ed2810e5a765327e7a6da0ca5d4854bf7a0b6f | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.04e-04 | 197 | 105 | 5 | 9ae6d987e65972e1fb21aa407788d5e3ff41ad64 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.04e-04 | 197 | 105 | 5 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | distal-Epithelial-Goblet-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.04e-04 | 197 | 105 | 5 | 3fbf456ae4f73da4f6254a6f0d24f0ec27d7a3cc | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.06e-04 | 198 | 105 | 5 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | medial-Epithelial-Basal|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | fa7584e3cc0f8cbdd6a76c6a0faee26b0922c4ae | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 199 | 105 | 5 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | medial-Epithelial-Basal-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | fc37f8868417308fb4410684d0d1e506cec30f35 | |
| ToppCell | medial-2-Epithelial-Basal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.09e-04 | 199 | 105 | 5 | 10af93596cc6d5da4cf5052707ff5f7fc347dc84 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 105 | 5 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.09e-04 | 199 | 105 | 5 | ba284f984909504221900bca5ea12ada5b2ffd9f | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5AC+_High|Biopsy_IPF / Sample group, Lineage and Cell type | 1.09e-04 | 199 | 105 | 5 | 51cb306e36537a53968c55187bd87c83e1706187 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.09e-04 | 199 | 105 | 5 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 199 | 105 | 5 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | afac850d5a40de0d6f02857cf81a19443d90b1eb | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.11e-04 | 200 | 105 | 5 | 592c7c3ded409a9957cbcdc62fcc213fa8eae598 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 200 | 105 | 5 | 80e0483d5ab0c6213aae0ec62619f57e6ec0e4c2 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.11e-04 | 200 | 105 | 5 | 8cfbde43c5e66269ad128aa5398b1517667d7d36 | |
| ToppCell | distal-Epithelial-Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 200 | 105 | 5 | 5c14f0c09bb8b3daf6d649032e888a7880c52b73 | |
| ToppCell | distal-Epithelial-Basal-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 200 | 105 | 5 | 6f00d08e93f89b3575ebbd5c2f451e655d449ef3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 200 | 105 | 5 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_basal-Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | 0594ca7bc313b73e1dc800cf058f8f798b0284cb | |
| ToppCell | distal-2-Epithelial-Basal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.11e-04 | 200 | 105 | 5 | 9beb128841c50241aa819261f21bf66f881ea125 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.11e-04 | 200 | 105 | 5 | 61811380d9252f12f27b7ad4752380b52692677f | |
| Drug | AC1MPID6 | 1.03e-11 | 6 | 103 | 5 | CID003411618 | |
| Drug | AC1MQWF5 | 4.25e-10 | 10 | 103 | 5 | CID003458642 | |
| Drug | AC1MPID3 | 1.90e-08 | 19 | 103 | 5 | CID003411617 | |
| Drug | (2S,3R,4S,5S,6R)-2-benzyl-6-(hydroxymethyl)oxane-3,4,5-triol | 5.42e-08 | 23 | 103 | 5 | CID010332525 | |
| Drug | 2'-fucosyllactose | 2.24e-07 | 30 | 103 | 5 | CID000170484 | |
| Drug | lacto-N-tetraose | 3.14e-07 | 32 | 103 | 5 | CID000440993 | |
| Drug | NSC638615 | 5.68e-07 | 107 | 103 | 7 | CID000097535 | |
| Drug | NSC35456 | 1.82e-06 | 45 | 103 | 5 | CID000006725 | |
| Drug | diosmetin | 2.42e-06 | 85 | 103 | 6 | CID005281612 | |
| Drug | AC1Q5O3K | 2.80e-06 | 49 | 103 | 5 | CID000001529 | |
| Drug | AC1L2R6I | 7.44e-06 | 28 | 103 | 4 | CID000126931 | |
| Drug | (Z)-7-[(1S,4R,6R)-5-[(E)-oct-1-enyl]-2,3-diazabicyclo[2.2.1]hept-2-en-6-yl]hept-5-enoic acid | 1.05e-05 | 10 | 103 | 3 | CID009905657 | |
| Drug | aminopyrine | 1.29e-05 | 171 | 103 | 7 | CID000006009 | |
| Drug | propoxyphene | 1.33e-05 | 67 | 103 | 5 | CID000010100 | |
| Drug | GDP-fucose | 1.43e-05 | 68 | 103 | 5 | CID000000451 | |
| Drug | carteolol | 1.89e-05 | 72 | 103 | 5 | CID000002583 | |
| Drug | sLex | 1.89e-05 | 72 | 103 | 5 | CID004564901 | |
| Drug | 82570-34-1 | 2.03e-05 | 2 | 103 | 2 | CID000174280 | |
| Drug | azo analog I | 2.49e-05 | 13 | 103 | 3 | CID006438575 | |
| Drug | chloral hydrate | 2.68e-05 | 129 | 103 | 6 | CID000002707 | |
| Drug | sLea | 2.79e-05 | 78 | 103 | 5 | CID000643993 | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 1478_DN | |
| Drug | ST021200; Up 200; 10uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 7559_UP | |
| Drug | Doxylamine succinate [562-10-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 4235_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 3732_DN | |
| Drug | trimipramine | 3.16e-05 | 80 | 103 | 5 | CID000005584 | |
| Drug | 3'-sialyl LewisX | 3.21e-05 | 197 | 103 | 7 | CID000643990 | |
| Drug | Gentamicine sulfate [1405-41-0]; Up 200; 2.6uM; PC3; HT_HG-U133A | 3.21e-05 | 197 | 103 | 7 | 5883_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; HL60; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 2449_DN | |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 3.42e-05 | 199 | 103 | 7 | 4115_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 3.53e-05 | 200 | 103 | 7 | 1666_DN | |
| Drug | 3'SLN | 3.93e-05 | 15 | 103 | 3 | CID000643986 | |
| Drug | GDP-Man | 4.25e-05 | 140 | 103 | 6 | CID000000732 | |
| Drug | 2a-e | 4.26e-05 | 43 | 103 | 4 | CID000006942 | |
| Drug | diclofenac | 4.67e-05 | 209 | 103 | 7 | CID000003032 | |
| Drug | mephenytoin | 5.00e-05 | 88 | 103 | 5 | CID000004060 | |
| Drug | lacto-N-neotetraose | 5.57e-05 | 46 | 103 | 4 | CID000121853 | |
| Drug | camonagrel | 5.84e-05 | 17 | 103 | 3 | CID000065892 | |
| Drug | tienilic acid | 6.51e-05 | 93 | 103 | 5 | CID000038409 | |
| Drug | lansoprazole | 6.51e-05 | 93 | 103 | 5 | CID000003883 | |
| Drug | AC1L1KIN | 9.20e-05 | 100 | 103 | 5 | CID000005516 | |
| Drug | Sparteinum | 9.65e-05 | 101 | 103 | 5 | CID000003966 | |
| Drug | N-acetyllactosamine | 1.02e-04 | 164 | 103 | 6 | CID000000245 | |
| Drug | Hawleyite | 1.21e-04 | 4 | 103 | 2 | CID009793819 | |
| Drug | Triflusal | 1.21e-04 | 4 | 103 | 2 | DB08814 | |
| Drug | K-K-K | 1.46e-04 | 175 | 103 | 6 | CID000003823 | |
| Drug | miconazole | 1.48e-04 | 59 | 103 | 4 | CID000004189 | |
| Drug | metyrapone | 1.65e-04 | 179 | 103 | 6 | CID000004174 | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.75e-04 | 181 | 103 | 6 | 5419_DN | |
| Drug | dioxin | 1.82e-04 | 347 | 103 | 8 | CID000015625 | |
| Drug | AC1Q7AUJ | 1.93e-04 | 117 | 103 | 5 | CID000003303 | |
| Drug | 8-MOP | 2.01e-04 | 118 | 103 | 5 | CID000004114 | |
| Drug | isomallotochromanol | 2.01e-04 | 5 | 103 | 2 | CID000159574 | |
| Drug | loxoprofen | 2.01e-04 | 5 | 103 | 2 | ctd:C040656 | |
| Drug | 4-(nitroxy)butanoic acid 4-acetylaminophenyl ester | 2.01e-04 | 5 | 103 | 2 | ctd:C478738 | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.03e-04 | 186 | 103 | 6 | 6672_UP | |
| Drug | Miconazole | 2.16e-04 | 65 | 103 | 4 | ctd:D008825 | |
| Drug | Industrial Waste | 2.17e-04 | 26 | 103 | 3 | ctd:D007220 | |
| Drug | pioglitazone HCl; Up 200; 10uM; MCF7; HT_HG-U133A | 2.41e-04 | 192 | 103 | 6 | 6898_UP | |
| Drug | alprazolam | 2.48e-04 | 193 | 103 | 6 | CID000002118 | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.48e-04 | 193 | 103 | 6 | 5726_DN | |
| Drug | Podophyllotoxin [518-28-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.48e-04 | 193 | 103 | 6 | 6103_UP | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; PC3; HT_HG-U133A | 2.48e-04 | 193 | 103 | 6 | 6613_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 4838_UP | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 10uM; PC3; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 4331_DN | |
| Drug | NS-398; Up 200; 10uM; MCF7; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 6897_UP | |
| Drug | Thalidomide [50-35-1]; Up 200; 15.4uM; MCF7; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 2258_UP | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 2118_DN | |
| Drug | Atractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 3695_DN | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 4736_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Up 200; 15.6uM; HL60; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 2352_UP | |
| Drug | Sulfadoxine [2447-57-6]; Up 200; 12.8uM; PC3; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 5852_UP | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 7353_DN | |
| Drug | Ramipril [87333-19-5]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 3572_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; HL60; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 2742_UP | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 3881_UP | |
| Drug | Estropipate [7280-37-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 6068_UP | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 5805_DN | |
| Drug | C75; Up 200; 10uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 6399_UP | |
| Drug | hexobarbital | 2.82e-04 | 127 | 103 | 5 | CID000003608 | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 2288_UP | |
| Drug | Clebopride maleate [84370-95-6]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 5412_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 2542_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 4551_DN | |
| Drug | Mifepristone [84371-65-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 3185_UP | |
| Drug | Iproniazide phosphate [305-33-9]; Up 200; 14.4uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 2125_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 5520_UP | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 6036_UP | |
| Drug | Nalidixic acid sodium salt hydrate; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 3668_DN | |
| Drug | Trimethylcolchicinic acid [3482-37-9]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 2802_DN | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; MCF7; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 3389_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 6830_DN | |
| Drug | ruban | 3.00e-04 | 6 | 103 | 2 | CID000087176 | |
| Drug | fructose-1,6-diphosphate | 3.00e-04 | 6 | 103 | 2 | ctd:C029063 | |
| Drug | ethyl 3-(3,4-dihydroxyphenyl)acrylate | 3.00e-04 | 6 | 103 | 2 | CID000066883 | |
| Drug | rossicaside B | 3.00e-04 | 6 | 103 | 2 | ctd:C547390 | |
| Drug | cyclolinteinone | 3.00e-04 | 6 | 103 | 2 | CID006444308 | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.01e-04 | 200 | 103 | 6 | 4094_UP | |
| Drug | AC1L1F9Q | 3.09e-04 | 201 | 103 | 6 | CID000003144 | |
| Disease | alpha-(1;3)-fucosyltransferase 5 measurement | 1.42e-07 | 4 | 98 | 3 | EFO_0021979 | |
| Disease | candidiasis (implicated_via_orthology) | 3.57e-07 | 44 | 98 | 5 | DOID:1508 (implicated_via_orthology) | |
| Disease | galactoside 3(4)-L-fucosyltransferase measurement | 1.23e-06 | 7 | 98 | 3 | EFO_0021853 | |
| Disease | alpha-(1,3)-fucosyltransferase 5 measurement | 1.23e-06 | 7 | 98 | 3 | EFO_0020136 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 1.09e-05 | 2 | 98 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | carbohydrate measurement | 1.68e-05 | 46 | 98 | 4 | EFO_0004998 | |
| Disease | serum carcinoembryonic antigen measurement | 3.89e-05 | 20 | 98 | 3 | EFO_0005760 | |
| Disease | cancer antigen 19.9 measurement | 6.52e-05 | 4 | 98 | 2 | EFO_0010584 | |
| Disease | polyp of gallbladder | 6.52e-05 | 4 | 98 | 2 | MONDO_0021416 | |
| Disease | lymphocyte count | THEMIS2 JCAD SLC4A7 STRBP CYP21A2 ERVW-1 ZNF295-AS1 ZNF469 ANTXR2 PKP3 SLC22A4 ILDR1 FUT7 FAM177A1 IL27RA | 9.55e-05 | 1464 | 98 | 15 | EFO_0004587 |
| Disease | desmoglein-2 measurement | 1.08e-04 | 5 | 98 | 2 | EFO_0020322 | |
| Disease | level of V-set and immunoglobulin domain-containing protein 2 in blood serum | 1.08e-04 | 5 | 98 | 2 | OBA_2044774 | |
| Disease | Endometrial Stromal Sarcoma | 1.08e-04 | 5 | 98 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 1.62e-04 | 6 | 98 | 2 | C0334488 | |
| Disease | lactoperoxidase measurement | 1.62e-04 | 6 | 98 | 2 | EFO_0020525 | |
| Disease | urinary potassium to creatinine ratio | 1.62e-04 | 6 | 98 | 2 | EFO_0009882 | |
| Disease | Ovarian Cysts | 2.15e-04 | 35 | 98 | 3 | C0029927 | |
| Disease | Corpus Luteum Cyst | 2.15e-04 | 35 | 98 | 3 | C0010093 | |
| Disease | lithostathine-1-alpha measurement | 2.27e-04 | 7 | 98 | 2 | EFO_0801083 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 9.13e-04 | 57 | 98 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | cancer biomarker measurement | 1.11e-03 | 15 | 98 | 2 | EFO_0005127 | |
| Disease | anemia (implicated_via_orthology) | 1.11e-03 | 15 | 98 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | calcium measurement | 1.18e-03 | 628 | 98 | 8 | EFO_0004838 | |
| Disease | galectin-3 measurement | 1.27e-03 | 16 | 98 | 2 | EFO_0008137 | |
| Disease | Gastric ulcer | 1.61e-03 | 18 | 98 | 2 | C0038358 | |
| Disease | bipolar disorder, schizophrenia, response to lithium ion | 2.00e-03 | 20 | 98 | 2 | GO_0010226, MONDO_0004985, MONDO_0005090 | |
| Disease | axial length measurement | 2.17e-03 | 77 | 98 | 3 | EFO_0005318 | |
| Disease | N-glycan measurement | 2.42e-03 | 22 | 98 | 2 | EFO_0004999 | |
| Disease | e-selectin measurement | 2.42e-03 | 22 | 98 | 2 | EFO_0004575 | |
| Disease | Ureteral obstruction | 2.87e-03 | 24 | 98 | 2 | C0041956 | |
| Disease | Malignant neoplasm of breast | THEMIS2 STRBP CYP24A1 TRPC4 GRM6 PKDREJ PTGS1 NOS2 RUSF1 PLXNB1 | 3.03e-03 | 1074 | 98 | 10 | C0006142 |
| Disease | colon adenocarcinoma (is_marker_for) | 3.12e-03 | 25 | 98 | 2 | DOID:234 (is_marker_for) | |
| Disease | cholelithiasis | 3.18e-03 | 88 | 98 | 3 | EFO_0004799 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WEGGLVSWPPAPPLT | 16 | O43414 | |
| MPLPWSLALPLLLSW | 1 | Q8IUX8 | |
| WMSWVLPILSPLIPI | 511 | Q9N2J8 | |
| LVLWLPGLPRSSPSW | 31 | Q96L96 | |
| PPPLALPLHLGGWWV | 271 | Q8NCL9 | |
| PGSWLFPGLWLLVLS | 11 | P58335 | |
| GLWPWVLGLLSLPGV | 6 | Q6HA08 | |
| WIWLVPPMSGSITPV | 461 | P35228 | |
| PPESWKWILAPVILY | 266 | Q9Y5S8 | |
| SLVLPWSFPLEWAPQ | 61 | Q9H496 | |
| WALALGLVLLLPPWA | 166 | Q9GZN0 | |
| AWPSGTQQILLPPAW | 706 | Q9H2X6 | |
| PEFLLWALRPPGWLL | 196 | O60551 | |
| PTVDPTKLTWGPYLW | 86 | Q8N128 | |
| VIWPSVAPQSLPLWE | 481 | Q96QG7 | |
| ASPTPSRPVGVLLWW | 181 | P22083 | |
| VLADSSPRWLWGQPP | 491 | Q9P266 | |
| LPLPQPAQSWVWLVD | 1126 | Q15751 | |
| WWKLRSLHLPPLAPG | 21 | P08686 | |
| WALGTLPPPDALLLW | 256 | Q63HM2 | |
| GWVLPPLPSNDIWAT | 466 | Q8N8D1 | |
| ALWAGWVLTLQPLPP | 11 | O43157 | |
| RVASWGWPLTPTPLD | 576 | Q86V87 | |
| LLLCWLAAPWPTQPE | 11 | Q8N119 | |
| PGLSGAPSWWTLPLI | 26 | Q8NGJ8 | |
| WLSLPGLPPGWALFA | 86 | Q8N819 | |
| PAPQPTITILVWHWP | 41 | Q11130 | |
| LPAPWLLLCTWLPAG | 6 | Q86SU0 | |
| GAPFWLWPLPKLALL | 6 | Q6UWB1 | |
| LWGEWSPILSFQTPP | 216 | Q6UWB1 | |
| TLPDLPWGPCELWVT | 476 | Q6UWB1 | |
| PWVVATSVPLFWPLN | 86 | Q96P66 | |
| PWLPLGLLLWSGLAL | 16 | Q86WC4 | |
| PGLWTWLRNSLRPSP | 71 | P23219 | |
| CPPGSFWWLIPLLLL | 706 | P16144 | |
| PEGVSIWNPILLWQP | 126 | P15309 | |
| YGLAPPWPWSPVLLS | 371 | Q9BV87 | |
| WLWGAQPCLLLPIVP | 16 | O75173 | |
| VVRLSWSSPWAAPPL | 576 | O15303 | |
| WSSPWAAPPLLLAVL | 581 | O15303 | |
| LSPRPPLGSSLSPWW | 831 | Q8NHM5 | |
| PTSWPLLGSLLQILW | 61 | Q07973 | |
| EAGDLPVLLWWSPGL | 71 | Q495W5 | |
| LSWLGLRPVAASPWL | 6 | P98187 | |
| LPWLGLRPVATSPWL | 6 | Q9HCS2 | |
| SHAAWLLPGWLPLPS | 241 | Q16850 | |
| PTWGPLRGWPLELLC | 241 | Q12906 | |
| PLLWLLPHSWAVPEA | 16 | P28067 | |
| PFLPEALLTVWWLPF | 96 | Q9H0H9 | |
| TPAHSIPLILLWTWP | 56 | P51993 | |
| IPLILLWTWPFNKPI | 61 | P51993 | |
| SPWQWVTLLLGLLLP | 6 | P04180 | |
| DLWTPLIILWITLPP | 11 | P55286 | |
| SLWIPPTSRHPPTLW | 1921 | A6NE01 | |
| PVHLLGPPSSRWALW | 81 | Q96CH1 | |
| GRIWLVPPALDLSWI | 256 | Q96HA4 | |
| LPCAPGILSLWWVPE | 266 | Q9Y694 | |
| PWVPILKSLPLWAIV | 281 | Q9NRA2 | |
| PGVLCVPLWWFIPES | 266 | Q9H015 | |
| APPGAWPWLVRLQLG | 111 | P0CW18 | |
| LRWGPAPLLTPRGIW | 141 | Q9P2P1 | |
| LTPGRAQLLWSPWSP | 181 | Q0VD86 | |
| LLPWWLPQSPVPASG | 771 | Q8IVF1 | |
| LLPWWLPQSPVPASG | 771 | A6NNL0 | |
| PWWLPQSPVPASGLL | 701 | Q5VT03 | |
| LLPWWLPQSPVPASG | 771 | B1AL46 | |
| PLSLWPGTVPKEVRW | 51 | Q96PL5 | |
| PTLLILLWTWPFHIP | 61 | P21217 | |
| PAHPTLLILLWTWPF | 71 | Q11128 | |
| PLWTGFWPAPSLSLG | 316 | Q96GQ5 | |
| PILELSPPLWTAIGW | 291 | O75298 | |
| LIPDLVAGTPWPRWA | 36 | Q8NBV8 | |
| KWPLWLSPFQVVVIP | 606 | Q9BW92 | |
| FPGWVPWLLLGSVLI | 126 | P59536 | |
| LSQWMPWILPFLGPL | 441 | Q9UQF0 | |
| LLGHPISPIFGWLWP | 601 | Q9GZN6 | |
| PERGWIISPLGDNPW | 896 | Q9Y6M7 | |
| IISPLGDNPWWTLLI | 901 | Q9Y6M7 | |
| WRLWPTLHLDPLSPK | 661 | Q7Z494 | |
| AWLGALPIPLDWERP | 166 | Q07326 | |
| WLEAWRVSPLPLSPL | 116 | Q9UK53 | |
| LKWPWASGPVLTLLP | 406 | Q9NTG1 | |
| VNLPPLPLCGWAPWL | 1316 | Q8TE82 | |
| RVPTWAPLKGWPLEL | 231 | Q96SI9 | |
| GSDIWWTLPPEQLLP | 561 | Q9NSE4 | |
| WVLLLLGPCAAPPAW | 16 | P08514 | |
| AWPQELLWAVLPLLP | 861 | Q7RTU9 | |
| VAPWTALLALGLPGW | 16 | Q9C0B6 | |
| WGWASPLRQFSILPP | 1121 | Q8N3C0 | |
| GALPPWLSPWLLLAL | 141 | Q9Y3P4 | |
| PKGLEWLWSPQIVGL | 596 | Q9Y446 | |
| RLWEVLWTGLPGPNL | 511 | Q9HA65 | |
| LVPWLLLGASWLIPQ | 166 | Q6NTF9 | |
| SLWEPPRSGLPLWAE | 166 | Q9BTD3 | |
| PFWTWEPSAPRTLLQ | 166 | Q5TEJ8 | |
| LGPNPWWTVIAAIIP | 806 | Q6U841 | |
| EELTPATPLWIIGWG | 316 | Q9NRS4 | |
| LLRLWEELGPWPGLV | 106 | Q86VD9 | |
| SLPSWLPGLPSLEWG | 6 | A0PJX8 | |
| PGIDPWAPGLSLWAL | 2921 | Q96JG9 | |
| AWPQELLWAVLPLLP | 861 | A6NGW2 | |
| SWPLLFFPLLWALPL | 296 | Q9Y6M0 | |
| LLAPPSSSWTLWVAP | 36 | Q8N0V1 | |
| AGPVRPELWLLLWAA | 11 | O75093 | |
| PRWDPFPLLTAVVWG | 151 | Q9Y6I8 | |
| VPPIQWLAWIPQLLT | 3226 | Q9Y4A5 | |
| PLRPGPWTVRLLQFW | 721 | Q9H1B5 | |
| GPPPTIVEWMILPWV | 396 | Q9UBN4 | |
| WPPHPLQIVAWLLYL | 46 | Q8WTX9 | |
| ALGPRNPWTLWTPLT | 81 | Q8WUU4 | |
| MGLPVSWAPPALWVL | 1 | Q9H400 |